Cargando…
Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?
In the UK there are standardized surveillance procedures for gestational trophoblastic disease. However, there are differences in practice between the two treatment centres in terms of definition of persistent gestational trophoblastic disease, prognostic risk assessment and chemotherapeutic regimen...
Autores principales: | Gillespie, A M, Siddiqui, N, Coleman, R E, Hancock, B W |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362241/ https://www.ncbi.nlm.nih.gov/pubmed/10098770 http://dx.doi.org/10.1038/sj.bjc.6690203 |
Ejemplares similares
-
Placental site trophoblastic tumour: a rare but potentially curable cancer
por: Gillespie, A M, et al.
Publicado: (2000) -
Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis
por: Sharma, S, et al.
Publicado: (1999) -
Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy
por: Gillespie, A M, et al.
Publicado: (2000) -
Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease
por: Dobson, L S, et al.
Publicado: (2000) -
Hyperthyroidism and human chorionic gonadotrophin production in gestational trophoblastic disease
por: Walkington, L, et al.
Publicado: (2011)